TB vaccine enters new clinical trials
Thursday, April 23, 2009 - 14:28
in Health & Medicine
(PhysOrg.com) -- The world`s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate vaccine for more than 80 years to get to this advanced stage of clinical trials in infants.